Zhejiang Xianju Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000K64
CNY
8.15
-0.16 (-1.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,734.00
3,979.57
4,086.55
4,351.98
4,308.87
3,994.30
3,683.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,734.00
3,979.57
4,086.55
4,351.98
4,308.87
3,994.30
3,683.02
Raw Material Cost
1,526.54
1,753.17
1,991.41
1,879.48
1,861.16
1,832.78
1,514.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
706.40
608.94
553.93
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.90
5.77
6.64
12.27
32.11
69.41
71.69
Selling and Distribution Expenses
1,450.28
1,312.63
1,225.39
1,503.72
1,511.42
1,292.12
1,386.60
Other Expenses
-42.13
-35.95
-30.71
24.57
19.86
13.03
12.62
Total Expenditure (Excl Depreciation)
3,267.83
3,321.00
3,470.29
3,641.21
3,603.31
3,324.63
3,098.82
Operating Profit (PBDIT) excl Other Income
466.2
658.6
616.3000000000001
710.8
705.6
669.7
584.2
Other Income
150.54
-84.75
57.39
211.52
75.94
14.26
36.44
Operating Profit (PBDIT)
790.59
753.95
872.97
1,074.29
943.38
835.06
746.33
Interest
5.90
5.77
6.64
12.27
32.11
69.41
71.69
Exceptional Items
-1.76
-0.21
3.39
8.39
-1.57
29.70
-2.98
Gross Profit (PBDT)
2,207.47
2,226.41
2,095.14
2,472.50
2,447.71
2,161.52
2,168.67
Depreciation
220.15
227.88
220.09
194.65
192.75
179.21
148.89
Profit Before Tax
562.78
520.09
649.63
875.76
716.95
616.14
522.78
Tax
83.24
98.40
79.56
124.51
108.01
92.25
84.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
449.64
397.18
563.08
749.40
615.94
504.51
410.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
449.64
397.18
563.08
749.40
615.94
504.51
410.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.96
2.74
-0.97
-2.02
1.94
24.49
32.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
452.60
399.92
562.12
747.39
617.88
529.00
442.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,035.11
5,843.50
5,786.12
5,457.45
4,829.23
4,444.93
2,941.52
Earnings per share (EPS)
0.45
0.4
0.57
0.76
0.62
0.51
0.45
Diluted Earnings per share
0.45
0.4
0.57
0.76
0.62
0.51
0.45
Operating Profit Margin (Excl OI)
11.25%
15.35%
14.57%
15.35%
15.66%
16.06%
15.23%
Gross Profit Margin
20.97%
18.8%
21.28%
24.6%
21.11%
19.91%
18.24%
PAT Margin
12.04%
9.98%
13.78%
17.22%
14.29%
12.63%
11.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -6.17% vs -2.62% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 13.18% vs -28.86% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -23.69% vs 2.83% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 1.72% vs -12.12% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Zhejiang Xianju Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,734.00
0
3,734.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,734.00
0
3,734.00
Raw Material Cost
1,526.54
0
1,526.54
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
706.40
0
706.40
Power Cost
0
0
0.00
Manufacturing Expenses
5.90
0
5.90
Selling and Distribution Expenses
1,450.28
0
1,450.28
Other Expenses
-42.13
0.00
-42.13
Total Expenditure (Excl Depreciation)
3,267.83
0
3,267.83
Operating Profit (PBDIT) excl Other Income
466.17
0.00
466.17
Other Income
150.54
0
150.54
Operating Profit (PBDIT)
790.59
0
790.59
Interest
5.90
0
5.90
Exceptional Items
-1.76
0
-1.76
Gross Profit (PBDT)
2,207.47
0
2,207.47
Depreciation
220.15
0
220.15
Profit Before Tax
562.78
0
562.78
Tax
83.24
0
83.24
Provisions and contingencies
0
0
0.00
Profit After Tax
449.64
0
449.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
449.64
0
449.64
Share in Profit of Associates
0
0
0.00
Minority Interest
2.96
0
2.96
Other related items
0.00
0.00
0.00
Consolidated Net Profit
452.60
0
452.60
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,035.11
0
6,035.11
Earnings per share (EPS)
0.45
0
0.45
Diluted Earnings per share
0.45
0
0.45
Operating Profit Margin (Excl OI)
11.25%
0%
0.00
11.25%
Gross Profit Margin
20.97%
0%
0.00
20.97%
PAT Margin
12.04%
0%
0.00
12.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 373.40 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -6.17% vs -2.62% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 45.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.18% vs -28.86% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 64.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -23.69% vs 2.83% in Dec 2024

Annual - Interest
Interest 0.59 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 1.72% vs -12.12% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.25%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024